HP (High Potency) APIs Global Market Report 2020-30: Covid 19 Impact and Recovery

Region:Global

Author(s):

Product Code:7641

Download Sample Report download
Buy the Full ReportStarting from $4000
Published on

April 2020

Total pages

300

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $4000

About the Report

About the Report

Major players in the high potency APIs (HPAPI) market are Eli Lily and Company, Novartis AG, Bristol-Myers Squibb Company, Roche Diagnostics Ltd., Sanofi, Hospira, Inc., BASF SE, Covidien plc, Boehringer Ingelheim GmbH and Merck & Co., Inc.
 
The global high potency APIs (HPAPI) market is expected to decline from USD 19.7 billion in 2019 to USD 18.5 billion in 2020 at a compound annual growth rate (CAGR) of -6%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe, resulting in patients of other illnesses including cancer and other immunodeficiency diseases delaying their episodes of care and restrictions on trade and exports owing to the lockdown of countries that manufacture the drug. The market is then expected to recover and reach USD 24.1 billion in 2023 at a CAGR of 5.2%.
 
The high potency APIs (HPAPI) market consists of sales of high potency active pharmaceutical ingredients and related services. High potency APIs are extremely effective in pharmacologically active ingredients. These are highly specific in their action and offer significant efficiency even at the low daily therapeutic doses. HPAPIs are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells.
 
The high potency APIs (HPAPI) market covered in this report is segmented by type into innovative HPAPI, generic HPAPI. It is also segmented by synthesis type into synthetic HPAPI, biotech HPAPI and by therapeutic application into oncology, harmonal disorder, glaucoma, other therapeutic applications (respiratory disorders, CVD, diabetes, cosmetology, and erectile dysfunction).
 
In August 2019, Permira Funds, a U.K based global investment firm, acquired Cambrex Corporation for USD 2.4 million.Through the acquisition Permira Funds will provide financial support to Cambrex Corporation for its expansion of product manufacturing and analytical testing services. Cambrex Corporation is a life sciences company that offers products and services for small molecule active pharmaceutical ingredients with its headquarters in U.S.A.
 
High investment requirements are anticipated to restrain the growth of the market over the coming years. The high potency APIs are cytotoxic, which are harmful to human cells. Moreover, they carry significant handling challenges including the requirement for specialized equipment to avoid cross-contamination, product protection, and to ensure environment and operator safety. Additionally, the requirement for appropriate process design and the constant evolution of technologies and industry standards, specialized containment facilities to facilitate the safety of the employees requires huge financial support. Therefore, large investment requirement acts as a major challenge for the growth of the high potency APIs market.
 
The companies dealing in the high potency APIs market are focusing on strategies such as production facility expansion and mergers & acquisitions to maintain their position in the competitive business environment. For instance, in 2017, Piramal Enterprises, an India based pharmaceuticals company, invested USD 55 million to enhance the capabilities of its five API manufacturing plants in India and U.S.A. In the following year, in October 2018, Lonza, a Switzerland based specialty contract development and manufacturing organization (CDMO) in biopharma industry, announced the expansion of its potent API (HPAPI) capacity by adding two new sites in order to support of antibody-drug conjugates (ADC) payload manufacturing.
 
The rising number of cancer cases coupled with increasing sales of cancer drugs contributed to the growth of the high potency APIs market. Rising incidence of cancer is resulting in increasing R&D about anticancer drugs which in turn is propelling the demand for high potency APIs market. According to the World Health Organization's International Agency for Research (IARC) on Cancer report published in September 2018, the cancer burden increased to 18.1 million new cases and 9.6 million deaths in 2018, globally. Moreover, 70% of deaths from cancer occur in middle and low-income countries. Therefore, the growing incidence of cancer cases is projected to upsurge revenues for the high potency APIs market.
 
 

Products

Products

1) By Type: Innovative HPAPI; Generic HPAPI; 2) By Synthesis Type: Synthetic HPAPI; Biotech HPAPI; 3) By Therapeutic Application: Oncology; Harmonal Disorder; Glaucoma; Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)


Companies

Eli Lily and Company; Novartis AG; Bristol-Myers Squibb Company; Roche Diagnostics Ltd.; Sanofi; Hospira, Inc.; BASF SE; Covidien plc; Boehringer Ingelheim GmbH; Merck & Co., Inc.; Sigma Aldrich Corporation; Bayer AG; Carbogen Amcis AG; Lonza; Teva Pharmaceutical Industries Ltd.; Pfizer Inc.; Mylan, Inc.; AbbVie; AstraZeneca plc; GlaxoSmithKline PLC

Table of Contents

Table of Contents

1. Executive Summary

2. High Potency APIs Market Characteristics

3. High Potency APIs Market Size And Growth

3.1. Global High Potency APIs Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global High Potency APIs Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. High Potency APIs Market Segmentation

4.1. Global High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Innovative HPAPI

Generic HPAPI

4.2. Global High Potency APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Synthetic HPAPI

Biotech HPAPI

4.3. Global High Potency APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Oncology

Harmonal Disorder

Glaucoma

Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

5. High Potency APIs Market Regional And Country Analysis

5.1. Global High Potency APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global High Potency APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific High Potency APIs Market

6.1. Asia-Pacific High Potency APIs Market Overview

6.2. Asia-Pacific High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China High Potency APIs Market

7.1. China High Potency APIs Market Overview

7.2. China High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India High Potency APIs Market

8.1. India High Potency APIs Market Overview

8.2. India High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan High Potency APIs Market

9.1. Japan High Potency APIs Market Overview

9.2. Japan High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia High Potency APIs Market

10.1. Australia High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia High Potency APIs Market

11.1. Indonesia High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea High Potency APIs Market

12.1. South Korea High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe High Potency APIs Market

13.1. Western Europe High Potency APIs Market Overview

13.2. Western Europe High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK High Potency APIs Market

14.1. UK High Potency APIs Market Overview

14.2. UK High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany High Potency APIs Market

15.1. Germany High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France High Potency APIs Market

16.3. France High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe High Potency APIs Market

17.1. Eastern Europe High Potency APIs Market Overview

17.2. Eastern Europe High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia High Potency APIs Market

18.1. Russia High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America High Potency APIs Market

19.1. North America High Potency APIs Market Overview

19.2. North America High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA High Potency APIs Market

20.1. USA High Potency APIs Market Overview

20.2. USA High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America High Potency APIs Market

21.1. South America High Potency APIs Market Overview

21.2. South America High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil High Potency APIs Market

22.1. Brazil High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East High Potency APIs Market

23.1. Middle East High Potency APIs Market Overview

23.2. Middle East High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa High Potency APIs Market

24.1. Africa High Potency APIs Market Overview

24.2. Africa High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. High Potency APIs Market Competitive Landscape And Company Profiles

25.1. High Potency APIs Market Competitive Landscape

25.2. High Potency APIs Market Company Profiles

25.2.1. Eli Lily and Company

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Novartis AG

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Bristol-Myers Squibb Company

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Roche Diagnostics Ltd.

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Sanofi

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The High Potency APIs Market

27. High Potency APIs Market Trends And Strategies

28. High Potency APIs Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global High Potency APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global High Potency APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global High Potency APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Global High Potency APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: Asia-Pacific, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: China, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: India, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: Japan, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: Australia, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: Indonesia, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: South Korea, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: Western Europe, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: UK, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: Germany, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: France, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Eastern Europe, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: Russia, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: North America, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: USA, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: South America, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: Brazil, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Middle East, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Africa, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 27: Eli Lily and Company Financial Performance

Figure 28: Novartis AG Financial Performance

Figure 29: Bristol-Myers Squibb Company Financial Performance

Figure 30: Roche Diagnostics Ltd. Financial Performance

Figure 31: Sanofi Financial Performance


List of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global High Potency APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global High Potency APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global High Potency APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Global High Potency APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: Asia-Pacific, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: China, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: India, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: Japan, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: Australia, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: Indonesia, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: South Korea, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: Western Europe, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: UK, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: Germany, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: France, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Eastern Europe, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: Russia, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: North America, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: USA, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: South America, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: Brazil, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Middle East, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Africa, High Potency APIs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 27: Eli Lily and Company Financial Performance

Table 28: Novartis AG Financial Performance

Table 29: Bristol-Myers Squibb Company Financial Performance

Table 30: Roche Diagnostics Ltd. Financial Performance

Table 31: Sanofi Financial Performance

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022